A new study reports small fragments of the rabies virus binds to, and inhibits, nicotinic acetylcholine receptors in the brain, inducing frenzied behaviors.
Study provides first potential targets for effective immune responses against COVID-19. The findings provide essential information for vaccine design against SARS-CoV-2.
